Latest filing published 02 Oct 2023 for Transcode Therapeutics, Inc., €47k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Robert Michael Dudley: trading record in brief
Robert Michael Dudley (chief executive) discloses dealings in Transcode Therapeutics, Inc. to SEC (Form 4). Between 27 May 2022 and 28 September 2023, the trades on record add up to 8 filings.
No open-market sale appears; the market trades are 8 purchases worth €264k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2023: 5 purchases and no sales on the market.
In size, the median ticket on the buying side is €38k. 1 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 2 October 2023 came the latest disclosure, an open-market purchase for €47k in Transcode Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Michael Dudley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 98,000 shares@ US$0.5120.5% of flowCommon StockSEC:0001104659-23-105924:0Canonical exit: 27 Dec 2023 (T+90)
- 6,607 shares@ US$2.54986.7% of flowCommon StockSEC:0001104659-23-073872:0Canonical exit: 18 Sept 2023 (T+90)
- 19,000 shares@ US$2.7621.0% of flowCommon StockSEC:0001104659-23-071204:0Canonical exit: 7 Sept 2023 (T+90)
- 19,000 shares@ US$2.7621.0% of flowCommon StockSEC:0001104659-23-070804:0Canonical exit: 7 Sept 2023 (T+90)
- 20,000 shares@ US$1.1510.0% of flowCommon StockSEC:0001104659-22-100931:0Canonical exit: 13 Dec 2022 (T+90)
- 28,000 shares@ US$1.844426.4% of flowCommon StockSEC:0001104659-22-067099:0Canonical exit: 25 Aug 2022 (T+90)
6 of 6 declarations